Abstract
In the last years, albuminuria has emerged as an important biomarker of CKD progression, risk of ESRD, cardiovascular disease and mortality. In the context of proteinuric renal diseases, albuminuria is largely used to assess risk of CKD progression and response to medical treatments. However, it is currently known that in a subgroup of CKD patients, albuminuria does not present a good per…